| Line item | 2025-09-30 FY | 2024-09-30 FY | 2023-09-30 FY | 2022-09-30 FY | 2021-12-31 FY | 2021-09-30 FY |
|---|---|---|---|---|---|---|
| Revenue | – | – | $1.45M | – | $0.00 | – |
| Cost of Revenue | – | – | $961.82K | – | – | – |
| Gross Profit | – | – | $486.36K | – | – | – |
| Operating Expenses | $110.65K | $312.07K | $1.90M | $204.13K | $38.27K | $2.39M |
| R&D | – | – | – | – | – | – |
| SG&A | $4.75K | $8.06K | $1.77M | $23.66K | $734.00 | $2.39M |
| Operating Income | -$110.65K | -$312.07K | -$1.41M | -$204.13K | -$38.27K | -$2.39M |
| Interest Expense | – | – | $10.75K | – | – | – |
| Tax Expense | – | – | $2.36K | – | $0.00 | – |
| Net Income | -$5.53M | -$710.09K | -$1.08M | -$204.13K | -$38.27K | -$2.39M |
| EPS (basic) | -0.1900 | 0.1200 | -0.0500 | -0.0300 | – | -1.4700 |
| EPS (diluted) | -0.1900 | 0.1200 | -0.0500 | -0.0300 | – | – |
| Shares (diluted) | $29.66M | $29.66M | $23.55M | $5.87M | – | – |